Purpose of the Test
- Identify ALK gene rearrangements in lung cancer patients.
- Assist oncologists in selecting appropriate targeted therapies (e.g., ALK inhibitors).
- Predict the patient's likelihood of responding to specific treatment protocols.
Book ALK Gene Rearrangement Test | Lahalak Medical Platform
An advanced genetic test to detect mutations in lung cancer, enabling the selection of targeted therapies that significantly improve treatment efficacy and patient outcomes for non-small cell lung cancer.
Scientific name: ALK Gene Rearrangement Testing
This test utilizes FISH or IHC techniques to detect ALK gene rearrangements in lung adenocarcinoma cells, essential for determining eligibility for modern targeted therapies and personalized treatment plans.
Service type
Oncology Genetic Test
Duration
15-30 minutes
Fasting
Fasting is not required
Included Services
- Biopsy sample processing
- FISH or IHC analysis
- Detailed medical result report
Medical Service Information
Target Groups
- Patients diagnosed with Non-Small Cell Lung Cancer (NSCLC).
- Individuals with lung adenocarcinoma.
- Patients seeking personalized treatment options after initial diagnosis.
Frequently Asked Questions
- Is this a blood test? Usually, it is performed on a tissue biopsy sample, though liquid biopsies may be used in specific cases.
- How long do results take? Results typically take 5 to 10 business days depending on laboratory processing.
Conditions & Notices
- Requires a tissue biopsy sample from the tumor
- Previous oncology medical reports must be provided
Medical services you might also like
